Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 11Carcinoma, Intraductal, Noninfiltrating 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Pain 2Neoplasms 2Breast Carcinoma In Situ 2Arthralgia 2Weight Loss 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Radiation Injuries 1Psoriasis 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Ovarian Neoplasms 1Osteoarthritis 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Malnutrition 1Lymphoma 1Leukemia 1Fatigue 1Dyspareunia 1Colonic Neoplasms 1Breast Neoplasms, Male 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Gemcitabine 6Pemetrexed 3Cisplatin 3Carboplatin 3atezolizumab 2Trastuzumab 2Sugammadex 2Paclitaxel 2Neostigmine 2vinflunine 1poly ICLC 1pembrolizumab 1motexafin gadolinium 1montanide ISA 51 1flt3 ligand protein 1enfortumab vedotin 1delta 24-sterol reductase 1daratumumab 1avelumab 1apatorsen 1abemaciclib 1Water 1Thalidomide 1Surveys and Questionnaires 1Saline Solution 1Rocuronium 1Nephroureterectomy 1Nephrectomy 1Neoadjuvant Therapy 1Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urologic Neoplasms × Fatty Acids, Omega-3 × Clear all
NCT03204266 2022-08-24

Oral Supplementation to Enhance Recovery Pilot Study

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
46 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡